Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria: A seroepidemiological study

Minerva Gastroenterologica e Dietologica

Volumn 50, Issue 1, 2004, Pages 89-96

  Atanasova, M V ^a   Haydouchka, I A ^a   Zlatev, S P ^a   Stoilova, Y D ^a   Iliev, Y T ^a   Mateva, N G ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Coinfection; Disease transmission, horizontal; Hepatitis B; Hepatitis C; Hepatitis C antibodies Seroprevalence; Risk factors

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 1.2 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD BORNE VIRUS; BULGARIA; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFORMED CONSENT; MALE; MORBIDITY; NORMAL HUMAN; QUESTIONNAIRE; RANDOMIZATION; RISK FACTOR; SCHOOL CHILD; SCREENING; SEROPREVALENCE; SUPERINFECTION; VIRUS CARRIER; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; BULGARIA; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

EID: 2442475208     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Badley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244;359-62.
2. Kuo G, Choo QL, Alter HJ. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244;362-4.
3. Global surveillance and control of hepatitis C. Report of WHO consultation organised in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
4. Consensus Panel: EASL International Consensus Conference on Hepatitis C. J Hepatol 1999;30:956-61.
5. Weekly epidemiological record 1999;49:425-7.
6. Zdraveopazvane 2000. Ministry of health, Regional center of Health, Plovdiv, 2001.
7. Lambova R, Andreev A, Gushterova A, Popov R. Serologic screening and epidemiologic investigation for viral infectious markers among volunteer blood donors. 6th National congress of clinical hematology and transfusion October 8-9 1998, Sofia, Bulgaria.
8. Draganov P, Teoharov P, Dimitrova T, Ivanova R, Kirjakov Z, Mushikov V et al. Incidence of HCV infection among patients and medical staff in dialisis centres. Infectology 1994;3;32-5.
9. Teoharov P, Kojoucharova M, Ivanova R, Mendizova A. Markers of hepatitis viruses in patients with cirrhosis. Infectology 2000;4;26-7.
10. Weekly Epidemiological Record 2000;3:18-9
11. Altinidis M. The prevalence of hepatitis B virus and hepatitic C virus infections in elderly persons in Afyon, Turkey. Arch Gastroenterohepatol 2001;20:1-2.
12. Salmeron FJ, Palacios A, Perez-Ruiz M, Torres C, Oyonarte S, Fernandez-Montoya A et al. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors. Dig Dis Sci 1996;41: 1933-8.
13. Vasconcelos HC, Yoshida CF, Vanderborght BO, Schatzmayr HG. Hepatitis B and C prevalence among blood donors in the south region of Brazil. Mem Inst Iswaldo Cruz 1994;89:503-7.
14. Gessoni G, Manoni F. Prevalence of anti-hepatitis C antibodies among teenagers in the Venetian area: a seroepidemiological study. Eur J Med 1993;2:79-82.
15. Lionis C, Koulentaki M, Biziagos E, Kouroumalis E. Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, Greece. J Viral Hepat 1997;4:55-61.
16. Palitzsch KD, Hottentrager B, Schlottmann K, Frick E, Holstege A, Scholmerich J et al. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol 1999;11: 1215-20.
17. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002;36:S30-4.
18. Rakadjieva T, Stoilova Y, Petrov A. A study on the basic epidemiological parameters of viral hepatitis A in the region of Plovdiv, Bulgaria. Folia Med 2002;3:11-4.
19. Meisal H, Reip A, Faltus B. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet 1995;345:1209-11.
20. Polywka S, Feucht H, Zöllner B, Laufs R. Hepatitis C virus in pregnancy and the risk of mother-to-child transmission. Eur J Clin Microbiol Infect Dis 1997;16: 121-4.
21. Demelia L, Vallebona E, Poma R, Sanna G, Masia G, Coppola RC. HCV transmission in family members of subjects with HCV related chronic liver disease. Eur J Epidemiol 1996;12:45-50.
22. Palitzsch KD, Hotentrager B, Schlottman K, Frick E, Holstege A, Scholmerich J et al. Prevalence of antibodies against hepatitis C in the adult German population. Eur J Gastroenterol Hepatol 1999;11:1215-20.
23. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Mover LA et al. The prevalence of hepatitis C virus infection in the Unated States 1988 through 1994. N Engl J Med 1999;341:557-62.
24. Crespo J, Losano JL, Carte B, de las Heras B, de la Cruz F, Pons-Romero F. Viral replication in patients with concomitant hepatitis B and C virus infections. Eur J Clin Microbiol Infect Dis 1997;16:445-51.
25. Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 1999;45: 284-8.